Investing Profile

Brett Zbar

VCInvestor
Managing Director and Global Head of Life Sciences
generalatlantic.comNew York, New York
Photo of Brett Zbar, Managing Partner at Foresite Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
McKinsey & Company Network
138 CONNECTIONS
Yale University Network
126 CONNECTIONS
General Atlantic Network
36 CONNECTIONS
Harvard Medical School Network
20 CONNECTIONS
cb
Foresite Capital Managing Partner
$100K - $5.0M
$1.5M
11
$668M
CompanyStageDateRound SizeTotal Raised
Pharvaris
Post Ipo EquityJun 2023$70M
Series CNov 2020$80M
Series BSep 2019$66M
$220M
Co-investors: Richard Gaster (venBio)
Javara Research
Series BApr 2022$40M
$40M
Centessa Pharmaceuticals
Series AFeb 2021$250M
$250M
Co-investors: Arjun Goyal (Vida Ventures)
Kinnate Biopharma
Series BDec 2019$75M
Series AApr 2018$22M
$200M
Co-investors: Carl Gordon (OrbiMed), Michael Rome (Foresite Capital), Peter Kolchinsky (RA Capital)
Replimune Group
Series BSep 2017$55M
$85M
Co-investors: Jason Rhodes (Atlas Venture)
Venatorx Pharmaceuticals
Series BJul 2017$42M
$76M
Co-investors: Carlo Rizzuto (Versant Ventures), Martin Heidecker (AMR Action Fund)
Aragon Pharmaceuticals
Series DOct 2012$50M
Series BApr 2010$22M
$80M
Co-investors: Carl Gordon (OrbiMed), Peter Svennilson (The Column Group), Josh Bilenker (Aisling Capital)
Managing Director and Global Head of Life Sciences General Atlantic2020 - Present
Managing Director Foresite Capital Management2015 - 2020
Partner Aisling Capital LLC2004 - 2014
Associate Principal McKinsey & Company1999 - 2004
Osler Medical Housestaff Johns Hopkins Hospital1998 - 1999
Harvard Medical School MD Medicine
Yale University BA Molecular Biophysics and Biochemistry; English